| Issues in the design of trials for the evaluation of psychopharmacological treatments for social phobia. | |
| | |
MedLine Citation:
|
PMID: 8923110 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Social phobia was neglected by psychopharmacologically oriented researchers until the past decade. Benefitting from the experience with other anxiety and other affective disorders, however, and also from unique interdisciplinary collaborative arrangements between psychopharmacological and cognitive behavioral investigators, treatment research in social phobia has made remarkable progress in the past few years. Not only has the field itself advanced, but investigative models have been created that are now being adopted and adapted for other disorders. |
| | |
Authors:
|
M R Liebowitz; R G Heimberg |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review |
Journal Detail:
|
Title: International clinical psychopharmacology Volume: 11 Suppl 3 ISSN: 0268-1315 ISO Abbreviation: Int Clin Psychopharmacol Publication Date: 1996 Jun |
Date Detail:
|
Created Date: 1997-03-12 Completed Date: 1997-03-12 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8609061 Medline TA: Int Clin Psychopharmacol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 49-53 Citation Subset: IM |
Affiliation:
|
Anxiety Disorders Clinic, New York State Psychiatric Institute, New York 10032, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Clinical Trials as Topic
/
methods* Humans Monoamine Oxidase Inhibitors / therapeutic use Phenelzine / therapeutic use Phobic Disorders / drug therapy* Research Design |
| Grant Support | |
ID/Acronym/Agency:
|
40121//PHS HHS; 44119//PHS HHS |
| Chemical | |
Reg. No./Substance:
|
0/Monoamine Oxidase Inhibitors; 51-71-8/Phenelzine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The neurobiology of social phobia.
Next Document: Issues in the design of trials for the evaluation of psychosocial treatments for social phobia.